1 Crucial Thing Investors Are Missing About Procter & Gamble's Sales

Core Insights - Procter & Gamble reported a surprising upside in its second quarter of fiscal 2025, achieving growth in key fundamentals without raising prices [1][4] - The company’s net sales increased by 2% year over year, reaching just under $21.9 billion, with core earnings also rising by 2$1.88 per share [2][3] Financial Performance - The 2% increase in net sales translates to approximately $500 million in additional revenue over the year, a significant achievement for a company of its size [3] - All five main product categories experienced stable or increased volume, with notable growth in baby, feminine, and family care, which saw a 4$7.575 billion, 2% growth - Baby, feminine, and family care: $5.298 billion, 4$3.848 billion, growth not applicable - Healthcare: $3.249 billion, 2$1.752 billion, 1% growth [5] Dividend and Shareholder Returns - Procter & Gamble is recognized as a Dividend King, having raised dividends for 68 consecutive years, which is among the longest streaks in the S&P 500 [7] - The company offers a generous dividend yield of 2.5%, significantly higher than the S&P 500 average of 1.2%, and plans to increase shareholder remuneration through dividend raises and share repurchases [8]